|
½ÃÀ庸°í¼
ÇåÆÃÅϺ´À» À§ÇÑ ¾àÁ¦ °³¹ß : Ȱ¹ßÇÑ ÆÄÀÌÇÁ¶óÀο¡¼ÀÇ Èñ¸Á°ú ±âȸ
Special Report: Huntington's Disease Drug Development--Hope and Opportunity in an Active Pipeline
|
Decision Resources, Inc. ¿¡¼ 2010³â 06¿ù ¿¡ ¹ßÇàÇÑ ¡¸ÇåÆÃÅϺ´À» À§ÇÑ ¾àÁ¦ °³¹ß : Ȱ¹ßÇÑ ÆÄÀÌÇÁ¶óÀο¡¼ÀÇ Èñ¸Á°ú ±âȸ¡¹ º¸°í¼´Â 32 Pages·Î ±¸¼ºµÇ¾î, US $9,200 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.
¹Ì±¹ ¹× À¯·´ÀÇ ÇåÆÃÅϺ´(HD : Huntington''s Disease) ȯÀÚ µ¿Çâ, ÇåÆÃÅϺ´ÀÇ º´ÀÎ, Áõ»ó, ÇöÀçÀÇ Ä¡·á¹ý ¹× »õ·Î¿î Ä¡·á¹ý, 2009³â ¹Ì±¹ÀÇ ÇåÆÃÅϺ´ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. 3. ÇåÆÃÅϺ´(HD : Huntington''s Disease)ÀÇ °³¿ä - ¹ßÁõ, Áõ»ó, Áø´Ü
- ÇåÆÃÅϺ´ÀÇ À¯ÀüÀÚÇÐ
- º´Å»ý¸®ÇÐ
5. ÇöÀçÀÇ Ä¡·á¹ý - ¿îµ¿Àå¾Ö °ü¸®¸¦ À§ÇÑ Ä¡·á¹ý
- ÇൿÇÐÀû Çö»ó(Behavioral Manifestations)À» À§ÇÑ Ä¡·á¹ý
6. »õ·Î¿î Ä¡·á¹ý - Disease-Modifying Therapies
- Symptomatic Therapies
8. ºÎ·ÏA : Èñ±Í ÀǾàǰ(Orphan Drug)ÀÇ ¿¬±¸°³¹ß, ¸¶ÄÉÆÃ¿¡ ´ëÇÑ Àå·Á ÇÁ·Î±×·¥ - FDA
- À¯·´ ÀǾ౹
- ¹Î°£Á¶Á÷ÀÇ Àμ¾Æ¼ºê
10. ºÎ·ÏB : Àü¹®°¡ ÀÎÅͺä LSH
|